Describes structure of phage P7-1, included in Armata’s Pseudomonas aeruginosa phage cocktail, AP-PA02 LOS ANGELES, May 4, 2026 /PRNewswire/ — Armata Pharmaceuticals, Inc. (NYSE American: ARMP) (“Armata” or the “Company”), a late clinical-stage biotechnology company focused on the…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
